Akari Therapeutics (AKTX) Non-cash Items (2014 - 2026)

Akari Therapeutics has disclosed Non-cash Items across 11 years of filings, most recently posting $88604.0 for Q1 2026.

• Non-cash Items for Q1 2026 came in at $88604.0, down 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $88604.0 (down 99.99% YoY), and the FY2024 annual result was $3.0 million, down 98.59% from the prior year.
• Non-cash Items came in at $88604.0 for Q1 2026 at Akari Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $1.6 billion in Q1 2025 to a low of $2.0 in Q3 2024.
• The 4-year median for Non-cash Items is $3.0 million (2024), against an average of $258.1 million.
• Across the five-year window, Non-cash Items jumped 108870950.0% in 2025 and plunged 99.99% in 2026, its largest moves.
• Akari Therapeutics' Non-cash Items stood at $212.5 million in 2023, then tumbled by 98.59% to $3.0 million in 2024, then dropped by 27.32% to $2.2 million in 2025, then tumbled by 95.93% to $88604.0 in 2026.
• The last three Non-cash Items figures came in at $88604.0 (Q1 2026), $2.2 million (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.